Cendrine D Robinson1, Amparo Gonzalez-Feliciano2, Lorelei A Mucci2, Sarah C Markt2. 1. Division of Cancer Prevention, National Cancer Institute, 9609 Medical Ctr Dr., Rockville, MD, 20850, USA. robinsoncd@mail.nih.gov. 2. Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Abstract
PURPOSE: Cigarette smoking among cancer survivors increases the risk of recurrence and secondary cancers. We sought to investigate smoking cessation following diagnosis of cancer compared to those not diagnosed with cancer. We also investigated cessation following diagnosis of a smoking-related and non-smoking-related cancer separately. METHODS: We conducted a matched cohort study within the Health Professionals Follow-Up Study (HPFS). We identified 566 men diagnosed with cancer who were current cigarette smokers at the time of diagnosis between 1986 and 2010 (exposed). Men diagnosed with cancer were age-matched 1:4 to men without a diagnosis of cancer who were also current cigarette smokers (unexposed). Multivariable conditional logistic regression models were used to calculate odds ratios (OR) and 95% confidence intervals (CI) to evaluate the association between a cancer diagnosis and smoking cessation within 2 and 4 years post diagnosis adjusted for potential confounders, overall and for smoking-related and non-smoking-related cancers. RESULTS: Of the men with cancer, 38% quit within 2 years and 42% within 4 years of diagnosis. Men diagnosed with cancer were more likely to quit smoking within 2 (OR = 2.5, 95% CI: 2.0-3.0) and 4 years (OR = 1.6, 95% CI: 1.3-2.0) post diagnosis, compared to matched men without cancer. The association was similar for smoking-related (OR = 3.4, 95%: 1.6-7.2) and non-smoking-related cancers (OR = 3.8, 95%: 2.8-5.2). CONCLUSIONS: Men diagnosed with cancer were more likely to quit smoking compared to men not diagnosed with cancer. A cancer diagnosis may be a "teachable moment" in which strategies to promote smoking cessation for individuals diagnosed with smoking-related and non-smoking-related cancers should be investigated. IMPLICATIONS FOR CANCER SURVIVORS: There is a continued need for the widespread implementation of cessation interventions for cancer survivors.
PURPOSE: Cigarette smoking among cancer survivors increases the risk of recurrence and secondary cancers. We sought to investigate smoking cessation following diagnosis of cancer compared to those not diagnosed with cancer. We also investigated cessation following diagnosis of a smoking-related and non-smoking-related cancer separately. METHODS: We conducted a matched cohort study within the Health Professionals Follow-Up Study (HPFS). We identified 566 men diagnosed with cancer who were current cigarette smokers at the time of diagnosis between 1986 and 2010 (exposed). Men diagnosed with cancer were age-matched 1:4 to men without a diagnosis of cancer who were also current cigarette smokers (unexposed). Multivariable conditional logistic regression models were used to calculate odds ratios (OR) and 95% confidence intervals (CI) to evaluate the association between a cancer diagnosis and smoking cessation within 2 and 4 years post diagnosis adjusted for potential confounders, overall and for smoking-related and non-smoking-related cancers. RESULTS: Of the men with cancer, 38% quit within 2 years and 42% within 4 years of diagnosis. Men diagnosed with cancer were more likely to quit smoking within 2 (OR = 2.5, 95% CI: 2.0-3.0) and 4 years (OR = 1.6, 95% CI: 1.3-2.0) post diagnosis, compared to matched men without cancer. The association was similar for smoking-related (OR = 3.4, 95%: 1.6-7.2) and non-smoking-related cancers (OR = 3.8, 95%: 2.8-5.2). CONCLUSIONS:Men diagnosed with cancer were more likely to quit smoking compared to men not diagnosed with cancer. A cancer diagnosis may be a "teachable moment" in which strategies to promote smoking cessation for individuals diagnosed with smoking-related and non-smoking-related cancers should be investigated. IMPLICATIONS FOR CANCER SURVIVORS: There is a continued need for the widespread implementation of cessation interventions for cancer survivors.
Authors: Jason T Newsom; Nathalie Huguet; Michael J McCarthy; Pamela Ramage-Morin; Mark S Kaplan; Julie Bernier; Bentson H McFarland; Jillian Oderkirk Journal: J Gerontol B Psychol Sci Soc Sci Date: 2011-10-09 Impact factor: 4.077
Authors: Peter G Shields; Roy S Herbst; Douglas Arenberg; Neal L Benowitz; Laura Bierut; Julie Bylund Luckart; Paul Cinciripini; Bradley Collins; Sean David; James Davis; Brian Hitsman; Andrew Hyland; Margaret Lang; Scott Leischow; Elyse R Park; W Thomas Purcell; Jill Selzle; Andrea Silber; Sharon Spencer; Tawee Tanvetyanon; Brian Tiep; Hilary A Tindle; Reginald Tucker-Seeley; James Urbanic; Monica Webb Hooper; Benny Weksler; C Will Whitlock; Douglas E Wood; Jennifer Burns; Jillian Scavone Journal: J Natl Compr Canc Netw Date: 2016-11 Impact factor: 11.908
Authors: J Lee Westmaas; Christina C Newton; Victoria L Stevens; W Dana Flanders; Susan M Gapstur; Eric J Jacobs Journal: J Clin Oncol Date: 2015-04-20 Impact factor: 44.544
Authors: J Michael Underwood; Julie S Townsend; Eric Tai; Arica White; Shane P Davis; Temeika L Fairley Journal: J Cancer Surviv Date: 2012-06-16 Impact factor: 4.442
Authors: P K Newby; Frank B Hu; Eric B Rimm; Stephanie A Smith-Warner; Diane Feskanich; Laura Sampson; Walter C Willett Journal: Am J Clin Nutr Date: 2003-11 Impact factor: 7.045
Authors: Jessica L Burris; Jamie L Studts; Antonio P DeRosa; Jamie S Ostroff Journal: Cancer Epidemiol Biomarkers Prev Date: 2015-08-17 Impact factor: 4.254
Authors: R V Karlsen; P E Bidstrup; J Christensen; S B Larsen; A Tjønneland; S O Dalton; C Johansen Journal: Br J Cancer Date: 2012-05-29 Impact factor: 7.640